Hangzhou Tigermed Consulting Co. Ltd. provided earnings guidance for the year of 2021. For the year, the company expects Net profit attributable to shareholders of the Company between RMB 2,624,662,200 to RMB 3,027,110,400 and Basic earnings per share between RMB 3.01 per share to RMB 3.47 per share.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
54.91 CNY | -0.36% | -3.65% | -0.11% |
04-25 | Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 | MT |
04-25 | Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.11% | 6.18B | |
+67.53% | 62.86B | |
-0.77% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+13.30% | 26.46B | |
-22.79% | 18.9B | |
+4.70% | 12.67B | |
+24.10% | 12.27B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- 300347 Stock
- News Hangzhou Tigermed Consulting Co., Ltd
- Hangzhou Tigermed Consulting Co., Ltd Provides Earnings Guidance for the Year of 2021